TORONTO, May 3, 2018 /PRNewswire/ – Beleave Inc. (“Beleave” or the “Company”) (CSE: BE; OTCQX: BLEVF) is pleased to announce initial projections for the sale of medical cannabis . The Company is currently operating out of its 14,500 sq. ft. facility in Hamilton, ON with its additional 80,000 sq. ft. Read More
The post Beleave Provides Baseline Medical Cannabis Yield Projections appeared first on Dagga Magazine.